We studied the effect of pravastatin on coronary perfusion after percutaneous, transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.
Effect of Pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty / MANFRINI O; PIZZI C; MORGAGNI GL; FONTANA F; BUGIARDINI R.. - In: THE AMERICAN JOURNAL OF CARDIOLOGY. - ISSN 0002-9149. - STAMPA. - 93:11(2004), pp. 1391-1393. [10.1016/j.amjcard.2004.02.037]
Effect of Pravastatin on myocardial perfusion after percutaneous transluminal coronary angioplasty
MANFRINI, OLIVIA;PIZZI, CARMINE;FONTANA, FIORELLA;BUGIARDINI, RAFFAELE
2004
Abstract
We studied the effect of pravastatin on coronary perfusion after percutaneous, transluminal coronary angioplasty. An exercise test performed within 2 weeks after percutaneous transluminal coronary angioplasty induced reversible perfusion defects in 66% of patients taking pravastatin and 64% of those taking placebo. At follow-up, the exercise test still induced reversible perfusion defects in 3% of patients taking pravastatin and 29% of those taking placebo.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
